Literature DB >> 7798512

Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization.

K A Horvath1, W J Smith, R G Laurence, F J Schoen, R F Appleyard, L H Cohn.   

Abstract

OBJECTIVES: The short- and long-term effectiveness of transmyocardial laser revascularization was evaluated in the setting of an acute myocardial infarction.
BACKGROUND: Theoretically, transmyocardial laser revascularization allows direct perfusion of the ischemic area as ventricular blood flows through the channels to the myocardium.
METHODS: Infarcts were created by coronary occlusion in 30 sheep. Eighteen of these sheep were studied to assess short-term efficacy. The infarct was reperfused after 1 h by either removing the occlusion or by laser drilling using a high power carbon dioxide laser. The occlusions were left in place for the control group. To monitor regional recovery, percent systolic shortening was measured. To evaluate long-term effectiveness, 12 additional sheep underwent creation of an infarct. Six were treated with the laser, and six were untreated. The animals were restudied 30 days later.
RESULTS: In the short-term experiment, the control and reperfusion groups exhibited no recovery of regional contractility. The laser group demonstrated improvement throughout the recovery period. There was a significant difference in the area of necrosis within the same area at risk (reperfusion group 44 +/- 6% and control group 39 +/- 5% vs. laser group 6 +/- 2%). After 30 days, none of the control animals showed evidence of contraction in the infarct, whereas the laser-treated animals did. Histologic analysis of the laser-treated infarcts revealed patent channels surrounded by viable myocardium. The control-group infarcts were necrotic and scarred.
CONCLUSIONS: On the basis of both short- and long-term improved contractility, as well as diminished necrosis in the area at risk, these results indicate that transmyocardial laser revascularization may be an alternative method of treating ischemic heart disease.

Entities:  

Mesh:

Year:  1995        PMID: 7798512     DOI: 10.1016/0735-1097(94)00410-r

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Cellular destruction following transmyocardial laser revascularization (TMR).

Authors:  S M Cherian; Y V Bobryshev; D Tran; A Sivaraman; R S A Lord; K M Cherian
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

2.  The prospective clinical and scintigraphic assessment of patients with preserved left ventricular systolic function after transmyocardial laser revascularisation.

Authors:  Miroslaw A Dziuk; Ana Canizales; Nidhal Ali; Hany El-Deeb; Keith E Britton; Duncan S Dymond; Stephen J Edmondson
Journal:  Int J Cardiovasc Imaging       Date:  2005-08       Impact factor: 2.357

Review 3.  Transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  J Card Surg       Date:  2008 May-Jun       Impact factor: 1.620

4.  [Histomorphology after transmyocardial laser revascularization].

Authors:  T Krabatsch; F Schäper; L Tambeur; C Leder; U Thalmann; R Hetzer
Journal:  Herz       Date:  1997-08       Impact factor: 1.443

5.  Transmyocardial revascularisation.

Authors:  T Wistow; P M Schofield
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

6.  The development of surgery of the coronary circulation: the Bigelow Lecture.

Authors:  D C Sabiston
Journal:  Ann Surg       Date:  1997-08       Impact factor: 12.969

7.  Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up.

Authors:  O H Frazier; Egemen Tuzun; Harald Eichstadt; Steven W Boyce; Allan M Lansing; Robert J March; Michele Sartori; Kamuran A Kadipasaoglu
Journal:  Tex Heart Inst J       Date:  2004

8.  [Long-term results of percutaneous transmyocardial laser revascularization therapy at the University of Vienna Medical Center].

Authors:  Melanie Gatterer; Mariann Gyöngyösi; Wolfgang Sperker; Christoph Strehblow; Aliasghar Khorsand; Senta Graf; Heinz Sochor; Dietmar Glogar
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

Review 9.  Novel revascularization therapies--TMLR and growth factor-induced angiogenesis monitored with cardiac MRI.

Authors:  N M Wilke; A Zenovich; O Muehling; M Jerosch-Herold
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.533

Review 10.  Transmyocardial revascularization devices: technology update.

Authors:  Bogdan A Kindzelski; Yifu Zhou; Keith A Horvath
Journal:  Med Devices (Auckl)       Date:  2014-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.